Rating Change #5
Greenlight Capital Re Ltd (GLRE - Get Report) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Highlights from the ratings report include:
- GLRE has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign.
- Net operating cash flow has increased to -$15.90 million or 16.94% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of 6.58%.
- GREENLIGHT CAPITAL RE LTD has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, GREENLIGHT CAPITAL RE LTD increased its bottom line by earning $0.35 versus $0.14 in the prior year. This year, the market expects an improvement in earnings ($4.40 versus $0.35).
- GLRE, with its very weak revenue results, has greatly underperformed against the industry average of 17.7%. Since the same quarter one year prior, revenues plummeted by 57.3%. Weakness in the company's revenue seems to have hurt the bottom line, decreasing earnings per share.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts